Stephanie Mehlis to Middle Aged
This is a "connection" page, showing publications Stephanie Mehlis has written about Middle Aged.
Connection Strength
0.084
-
Patient and physician perspectives on disease burden in chronic spontaneous urticaria: A real-world US survey. Ann Allergy Asthma Immunol. 2025 Mar; 134(3):315-323.e3.
Score: 0.056
-
Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label study. J Eur Acad Dermatol Venereol. 2025 Jun; 39(6):1152-1162.
Score: 0.014
-
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study. J Eur Acad Dermatol Venereol. 2017 Oct; 31(10):1693-1699.
Score: 0.008
-
Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis. Br J Dermatol. 2011 Sep; 165(3):652-60.
Score: 0.006